Cheryl R. Blanchard - 11 Mar 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
President, CEO, Director, Director
Signature
/s/ Cheryl R. Blanchard
Issuer symbol
ANIK
Transactions as of
11 Mar 2022
Net transactions value
+$207,143
Form type
4
Filing time
14 Mar 2022, 09:01:34 UTC
Previous filing
11 Mar 2022
Next filing
28 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Purchase $108,714 +4,287 +8.3% $25.36 56,179 11 Mar 2022 Direct F1
transaction ANIK Common Stock Purchase $98,429 +3,813 +6.8% $25.81 59,992 11 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 11, 2022, Dr. Blanchard purchased 4,287 shares in multiple trades ranging from $24.69 to $25.69. The price reported above reflects the weighted average purchase price. Dr. Blanchard undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
F2 On March 11, 2022, Dr. Blanchard purchased 3,813 shares in multiple trades ranging from $25.70 to $25.94. The price reported above reflects the weighted average purchase price. Dr. Blanchard undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.